Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial
Authors:
Open Access
- 23 November 2022
- journal article
- research article
- Published by Springer Nature in Drugs & Aging
- Vol. 40 (1) , 49-58
Abstract
Background Residents of aged-care facilities have high rates of adverse drug events. This study aimed to identify risk factors for adverse drug events in aged-care residents. Method This was a secondary study using data from a multicentre randomised controlled trial. Data from 224 residents for whom there was 6 months of baseline information were analysed. We assessed the risk of adverse drug events and falls (post hoc) in the subsequent 6 months. Adverse events were identified via a key word search of the resident care record and adjudicated by a multidisciplinary panel using a modified version of the Naranjo criteria. Covariates identified through univariable logistic regression, including age, sex, medicines, physical activity, cognition (Montreal Cognitive Assessment), previous adverse events and health service use were included in multivariable models. Results Overall, 224 residents were included, with a mean age of 86 years; 70% were female. 107 (48%) residents had an adverse drug event during the 6-month follow-up. Falls and bleeding were experienced by 73 (33%) and 28 (13%) residents, respectively. Age (odds ratio [OR] 1.05, 95% confidence interval [CI] 1.01–1.10), weight (OR 1.02, 95% CI 1.002–1.04), previous fall (OR 2.58, 95% CI 1.34–4.98) and sedative or hypnotic medicine use (OR 1.98, 95% CI 1.52–2.60) were associated with increased risk of adverse drug events. Increased cognition (OR 0.89, 95% CI 0.83–0.95) was protective. Risk factors for falls were previous fall (OR 3.27, 95% CI 1.68–6.35) and sedative or hypnotic medicines (OR 3.05, 95% CI 1.14–8.16). Increased cognition (OR 0.88, 95% CI 0.83–0.95) was protective. Conclusion Our results suggest residents with a previous fall, reduced cognition, and prescription of sedative or hypnotic medicines were at higher risk of adverse drug events and should be considered for proactive prevention.Keywords
Funding Information
- Australian Government Department of Health Pharmacy Trial Program
- University of South Australia
This publication has 59 references indexed in Scilit:
- Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancerBMC Medical Research Methodology, 2014
- Geriatric Conditions and the Risk of Adverse Drug Reactions in Older AdultsDrug Safety, 2012
- Validation of the GENEA AccelerometerMedicine & Science in Sports & Exercise, 2011
- Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort StudyAge and Ageing, 2009
- Epidemiology of medication-related adverse events in nursing homesThe American Journal of Geriatric Pharmacotherapy, 2006
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- The incidence of adverse drug events in two large academic long-term care facilitiesThe American Journal of Medicine, 2005
- Patient Risk Factors for Adverse Drug Events in Hospitalized PatientsArchives of internal medicine (1960), 1999
- A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validityJournal of Clinical Epidemiology, 1994
- Drug data coding and analysis in epidemiologic studiesEuropean Journal of Epidemiology, 1994